• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Methylosome protein 50 associates with the purinergic receptor P2X5 and is involved in osteoclast maturation.甲基体蛋白 50 与嘌呤能受体 P2X5 相关,参与破骨细胞成熟。
FEBS Lett. 2020 Jan;594(1):144-152. doi: 10.1002/1873-3468.13581. Epub 2019 Aug 31.
2
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.嘌呤能受体 P2X5 调节炎性体活性和小鼠破骨细胞的过度多核化。
Sci Rep. 2017 Mar 15;7(1):196. doi: 10.1038/s41598-017-00139-2.
3
MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.MEP50/PRMT5 通过组蛋白精氨酸甲基化降低基因表达,而蛋白激酶 Cδ/p38δ 信号传导可逆转这种情况。
J Invest Dermatol. 2016 Jan;136(1):214-224. doi: 10.1038/JID.2015.400.
4
Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.甲基osome蛋白50和蛋白激酶Cδ/ p38δ蛋白信号通过对p21Cip1基因表达的相反作用控制角质形成细胞增殖。
J Biol Chem. 2015 May 22;290(21):13521-30. doi: 10.1074/jbc.M115.642868. Epub 2015 Apr 7.
5
Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.PRMT5的抑制通过下调CXCL10和RSAD2来抑制破骨细胞分化,并部分预防卵巢切除诱导的骨质流失。
Cell Signal. 2017 Jun;34:55-65. doi: 10.1016/j.cellsig.2017.03.004. Epub 2017 Mar 14.
6
The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis.嘌呤能受体 P2X5 有助于实验性牙周炎中的骨丢失。
BMB Rep. 2018 Sep;51(9):468-473. doi: 10.5483/BMBRep.2018.51.9.126.
7
Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis.甲基osome蛋白50促进雄激素和雌激素非依赖性肿瘤发生。
Cell Signal. 2014 Dec;26(12):2940-50. doi: 10.1016/j.cellsig.2014.09.014. Epub 2014 Sep 30.
8
Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.萝卜硫素抑制 PRMT5 和 MEP50 的功能,抑制间皮瘤癌细胞表型。
Mol Carcinog. 2021 Jul;60(7):429-439. doi: 10.1002/mc.23301. Epub 2021 Apr 19.
9
MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.MEP50/PRMT5 介导的甲基化通过抑制 ITCH/NUMB 复合物的泛素化来激活 Hedgehog 信号通路中的 GLI1。
Commun Biol. 2019 Jan 18;2:23. doi: 10.1038/s42003-018-0275-4. eCollection 2019.
10
Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.PRMT5:MEP50 蛋白-蛋白相互作用抑制剂的发现与生物学特征分析。
J Med Chem. 2022 Oct 27;65(20):13793-13812. doi: 10.1021/acs.jmedchem.2c01000. Epub 2022 Oct 7.

引用本文的文献

1
A comprehensive investigation of PRMT5 in the prognosis and ion channel features of lung cancer.PRMT5在肺癌预后及离子通道特征方面的综合研究。
Front Oncol. 2024 Nov 29;14:1478672. doi: 10.3389/fonc.2024.1478672. eCollection 2024.
2
Molecular insights into P2X signalling cascades in acute kidney injury.急性肾损伤中 P2X 信号级联的分子机制。
Purinergic Signal. 2024 Oct;20(5):477-486. doi: 10.1007/s11302-024-09987-w. Epub 2024 Jan 22.
3
Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function.P2X5 受体的修复:对结构和功能的再评价。
Purinergic Signal. 2023 Jun;19(2):421-439. doi: 10.1007/s11302-022-09903-0. Epub 2022 Oct 24.
4
Protocadherin-7 Regulates Osteoclast Differentiation through Intracellular SET-Binding Domain-Mediated RhoA and Rac1 Activation.原钙黏蛋白-7 通过细胞内 SET 结合域介导的 RhoA 和 Rac1 的激活调控破骨细胞分化。
Int J Mol Sci. 2021 Dec 4;22(23):13117. doi: 10.3390/ijms222313117.
5
Exogenous adenosine activates A2A adenosine receptor to inhibit RANKL-induced osteoclastogenesis via AP-1 pathway to facilitate bone repair.外源性腺苷激活 A2A 腺苷受体,通过 AP-1 途径抑制 RANKL 诱导的破骨细胞生成,以促进骨修复。
Mol Biol Rep. 2022 Mar;49(3):2003-2014. doi: 10.1007/s11033-021-07017-1. Epub 2021 Nov 30.
6
Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis.从单核细胞-巨噬细胞融合和多核化中学习:骨质疏松症和类风湿关节炎的潜在治疗靶点。
Int J Mol Sci. 2020 Aug 20;21(17):6001. doi: 10.3390/ijms21176001.
7
Osteoclast Multinucleation: Review of Current Literature.破骨细胞多核化:文献综述。
Int J Mol Sci. 2020 Aug 8;21(16):5685. doi: 10.3390/ijms21165685.

本文引用的文献

1
Role of the purinergic P2X receptors in osteoclast pathophysiology.嘌呤能 P2X 受体在破骨细胞病理生理学中的作用。
Curr Opin Pharmacol. 2019 Aug;47:97-101. doi: 10.1016/j.coph.2019.02.013. Epub 2019 Apr 5.
2
The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis.嘌呤能受体 P2X5 有助于实验性牙周炎中的骨丢失。
BMB Rep. 2018 Sep;51(9):468-473. doi: 10.5483/BMBRep.2018.51.9.126.
3
Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity.更新骨免疫学:固有免疫和适应性免疫对骨细胞的调节。
Nat Rev Rheumatol. 2018 Mar;14(3):146-156. doi: 10.1038/nrrheum.2017.213. Epub 2018 Jan 11.
4
Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.缺氧敏感的COMMD1整合人类巨噬细胞中的信号传导与细胞代谢并抑制破骨细胞生成。
Immunity. 2017 Jul 18;47(1):66-79.e5. doi: 10.1016/j.immuni.2017.06.018.
5
Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.非小细胞肺癌细胞外体中包含的 Amphiregulin 通过激活 EGFR 通路诱导破骨细胞分化。
Sci Rep. 2017 Jun 9;7(1):3170. doi: 10.1038/s41598-017-03460-y.
6
Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.PRMT5的抑制通过下调CXCL10和RSAD2来抑制破骨细胞分化,并部分预防卵巢切除诱导的骨质流失。
Cell Signal. 2017 Jun;34:55-65. doi: 10.1016/j.cellsig.2017.03.004. Epub 2017 Mar 14.
7
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.嘌呤能受体 P2X5 调节炎性体活性和小鼠破骨细胞的过度多核化。
Sci Rep. 2017 Mar 15;7(1):196. doi: 10.1038/s41598-017-00139-2.
8
The Structure and Function of the PRMT5:MEP50 Complex.PRMT5:MEP50复合物的结构与功能
Subcell Biochem. 2017;83:185-194. doi: 10.1007/978-3-319-46503-6_7.
9
Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.细胞外ATP及其他核苷酸——细胞间信使释放的普遍触发因素。
Purinergic Signal. 2016 Mar;12(1):25-57. doi: 10.1007/s11302-015-9483-2. Epub 2015 Nov 6.
10
Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation.法托他汀是一种固醇调节元件结合蛋白(SREBP)抑制剂,通过抑制破骨细胞分化来预防核因子κB受体活化因子配体(RANKL)诱导的骨质流失。
Biochim Biophys Acta. 2015 Nov;1852(11):2432-41. doi: 10.1016/j.bbadis.2015.08.018. Epub 2015 Aug 28.

甲基体蛋白 50 与嘌呤能受体 P2X5 相关,参与破骨细胞成熟。

Methylosome protein 50 associates with the purinergic receptor P2X5 and is involved in osteoclast maturation.

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

出版信息

FEBS Lett. 2020 Jan;594(1):144-152. doi: 10.1002/1873-3468.13581. Epub 2019 Aug 31.

DOI:10.1002/1873-3468.13581
PMID:31432503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6957751/
Abstract

Purinergic signaling plays important roles in bone. P2X5, a member of ligand-gated ion channel receptors, has been demonstrated to regulate osteoclast maturation. However, the molecular mechanism of P2X5-mediated osteoclast regulation remains unclear. Here, we identified methylosome protein 50 (MEP50), a critical cofactor of the protein arginine methyltransferase 5 (PRMT5), as a P2X5-associating molecule. RNAi-mediated knockdown of MEP50 results in decreased formation of mature osteoclasts. MEP50 associates with P2X5, and this association requires the C-terminal intracellular region of P2X5. Additionally, impaired maturation of P2X5-deficient osteoclasts could be restored by transduction of full-length P2X5, but not a C-terminal deletion mutant of P2X5. These results indicate that P2X5 associates with MEP50 and suggest a link between the PRMT5 complex and P2X5 signaling in osteoclast maturation.

摘要

嘌呤能信号在骨骼中发挥重要作用。P2X5 是配体门控离子通道受体的成员,已被证明可调节破骨细胞成熟。然而,P2X5 介导的破骨细胞调节的分子机制尚不清楚。在这里,我们鉴定了甲基体蛋白 50(MEP50),一种蛋白质精氨酸甲基转移酶 5(PRMT5)的关键辅助因子,作为 P2X5 相关分子。MEP50 的 RNAi 介导的敲低导致成熟破骨细胞的形成减少。MEP50 与 P2X5 相关联,这种关联需要 P2X5 的胞内 C 末端区域。此外,通过转导全长 P2X5 可以恢复 P2X5 缺陷型破骨细胞的成熟障碍,但不能恢复 P2X5 的 C 末端缺失突变体。这些结果表明 P2X5 与 MEP50 相关联,并提示 PRMT5 复合物与 P2X5 信号在破骨细胞成熟中的联系。